Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study
Fleming, G. F., Filiaci, V. L., Bentley, R. C., Herzog, T., Sorosky, J., Vaccarello, L., Gallion, H.
Published in Annals of oncology (01.08.2004)
Published in Annals of oncology (01.08.2004)
Get full text
Journal Article
2A phase II study to determine the response to second curettage as initial management for persistent “low-risk” non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study
Filiaci, V.L, Mannel, R.S, Davidson, S.A, Hoffman, J.S, Spirtos, N.M, Chan, J.K, Schink, J.C, Tidy, J, Miller, D.S
Published in Gynecologic oncology (01.08.2014)
Published in Gynecologic oncology (01.08.2014)
Get full text
Journal Article
1A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial
Filiaci, V.L, Aghajanian, C, Cho, J, Kim, J.W, DiSilvestro, P.A, O'Malley, D, Rutherford, T.J, Van Le, L, Randall, M.E
Published in Gynecologic oncology (01.08.2014)
Published in Gynecologic oncology (01.08.2014)
Get full text
Journal Article
Evaluation of slide storage and detection of molecular markers by immunohistochemistry (IHC) in formalin-fixed, paraffin embedded endometrial cancer tissues from a clinical trial: A GOG study
Filiaci, V.L, Montag, A.G, Apushkin, M, Gomez, M.J, Marzullo, B, Monovich, L, Ramirez, N, Birrer, M.J, Olopade, O.I, Fleming, G
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
GOG 3007, a randomized phase II (RP2) trial of everolimus and letrozole (EL) or hormonal therapy (medroxyprogesterone acetate/tamoxifen, PT) in women with advanced, persistent or recurrent endometrial carcinoma (EC): A GOG Foundation study
Slomovitz, B.M., Filiaci, V.L., Coleman, R.L., Walker, J.L., Fleury, A.C., Holman, L.L., Miller, D.S.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article
Evidence for synthetic lethality between bevacizumab and chemotherapy in advanced, p53 null endometrial cancers
Mallen, A.R., Filiaci, V.L., Levine, D.A., Thiel, K., Aghajanian, C.A., Meng, X., Devor, E., Moore, K.N., Powell, M.A., Secord, A.A., Tewari, K.S., Bender, D.P., Stuckey, A.R., Fowler, J.M., Dewdney, S.B., Leslie, K.K.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article
Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P
Levine, D.A., Dizon, D.S., Carlson, J.W., Filiaci, V.L., Powell, M.A., Secord, A.A., Tewari, K.S., Bender, D.P., O'Malley, D.M., Stuckey, A.R., Moore, K.N., Dewdney, S.B., Gao, J., Dao, F., Soslow, R.A., Lankes, H.A., Aghajanian, C.A.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article